Director , MBBS, DCH, DNB, Fellowship, 21 years of experience
Gurgaon , India
Dr Satya Prakash Yadav is one the leading consultants in the field of Pediatric- Hemato-oncology & bone marrow transplant.
He has an experience of over 21 years and has performed more than 400 blood &marrow transplants including 50 unrelated donor/cord transplants and 50 Haplo identical Bone marrow transplants.
Dr Prakash has completed his MBBS from University College of Medical Sciences, Delhi, and DCH from the prestigious Maulana Azad Medical College (MAMC), New Delhi.Following which he did his DNB (Paediatrics) from Sri Ganga Ram.
He has also done his Fellowship in pediatric Haematology from The Children’s Hospital at Westmead, Sydney (Australia)
Dr Satya Prakash Yadav has trained nearly 20 fellows in paediatric haematology & oncology who are working as consultants within and outside India.
He has been associated with various renowned organizations such as American Society of Haematology (ASH),American Society of Clinical Oncology (ASCO),International Society of Pediatric Oncology (SIOP),Pediatric Hemato-Oncology (PHO) Chapter of Indian Academy of Pediatrics (IAP)
Dr Prakash has his expertise in paediatric Leukaemia and blood & marrow transplantation.
Fellowship, The Children’s Hospital at Westmead ,Australia
Hemophilia Academy Fellow :2 week training in Hemophilia in Edinburgh
ANZCCSG Scholarship:To present paper during SIOP meeting in Brisbane 2010
National Co-coordinator - National Training program in practical pediatric hematology (NTPPPH)- train pediatricians in hematology across India
Editor- Oncopedia :Doing editorial work for Cure4kids, St Jude’s Hospital, USA
Dr Prakash has various publications nationally and internationally.
Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukemia: British Journal of Hematology
Outcome of Paediatric Acquired Aplastic Anemia: A Developing World Experience : Pediatr Hematol Oncology
Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis: A Single Centre Experience : Indian J Pediatr
Management of childhood brain tumors: consensus report by the Pediatric Hematology Oncology (PHO) Chapter of Indian Academy of Paediatrics (IAP) :Indian J Pediatric
DOCTORS SIMILAR TO Dr Satya Prakash Yadav
Dr. Raghuram C. P. - Consultant, Paediatric Oncologist
Vaidam is NABH certified healthcare discovery platform that will connect you to top-notch medical experts, hospitals, wellness options, and trusted travel partners in India to help identify and make the right healthcare choices.
Researched & Personalized Treatment Plan - Under One Roof
You can search for the best hospitals in India to treat cancer and ailments of the heart, bones or kidney, read about them, view photographs of the facilities at the hospitals and the places at which the hospitals are located, and check the cost of treatment.
Quality Treatment Within Your Budget
As soon as you post an enquiry, the patient relation team will collect details from you, share them with the doctors and hospitals on Vaidam's panel, and get a personalized treatment plan. We research to get quality treatment within your budget.
Treatment to Travel
Vaidam concierge assists patients, to get medical Visa to travel to India, the best airline fares and arrangements for your stay. Our concierge also helps you with daily travel, language, and food concerns. Vaidam does everything to be your perfect host in India. All of Vaidam’s services are free of cost to patients.
If you are looking for medical care in New Delhi, Mumbai, Chennai, Hyderabad or Ahmedabad, Vaidam Health has a network in each of those cities.
Note: Vaidam Health does not provide medical advice, diagnosis or treatment. The services and information offered on www.vaidam.com are intended solely for informational purposes and cannot replace the professional consultation or treatment by a physician. Vaidam Health discourages copying, cloning of its webpages and its content and it will follow the legal procedures to protect its intellectual property